Class II — MRP, LLC dba Aquabiliti
| Recalling firm | MRP, LLC |
|---|---|
| Registered facility | Aquabiliti (the firm's only registered facility) |
| Classification | Class II |
| Status | Ongoing |
| Reason | The saline flush syringes may fail to meet USP criteria for stated sodium chloride content after 12 months. |
| Product | AQUABILITI AQUASTAT 0.9% Sodium Chloride Injection syringe, USP, 5mL in 12mL, REF 2T0805; and 3mL in 12mL, REF 2T0807, intermediate cartons containing 100 syringes, shipping cases containing 400 syringes, Rx, Sterile. |
| Quantity | 3,080,000 syringes |
| Distribution | US Nationwide distribution in the states CO, FL, NC, NY, OH, PA, TN, TX, and VA. |
| Initiated | 2023-12-28 |
| Classified | 2024-02-22 |
| Recall number | Z-1174-2024 |
| Initiation | Voluntary: Firm initiated |
Source: U.S. FDA via openFDA (opens in a new tab) (device registration & enforcement). Data as of 2026-10-06. Verify this recall record at FDA → (opens in a new tab)
Cite this record
RegWarden. “Class II recall — MRP, LLC dba Aquabiliti (Z-1174-2024).” Compiled from U.S. FDA public records (openFDA; FDA Data Dashboard). Data as of 2026-10-06. https://regwarden.com/recall/93848/
Alerts for MRP, LLC
Watchlist alerts will email you when FDA publishes a new recall, inspection classification, or warning letter for a facility you follow. They aren't open to the public yet — leave your email and we'll tell you when they are.
Want a one-page facility brief?
A single-page summary of this facility's registration and recall history for diligence. Not selling it yet — register interest and we'll follow up.